IIL Approves Q4/FY26 Results, ESPS 2026, and Key Management Changes

Insecticides (India) Limited's Board approved its Audited Financial Results for Q4 and the full year ended March 31, 2026, based on an unmodified auditor's opinion. The Board also formulated the Employee Stock Purchase Scheme 2026 (IIL ESPS Scheme 2026), allowing for the issuance of up to 2,00,000 equity shares with a face value of ₹10 each. These shares will have a one-year lock-in period and are available to employees of subsidiary companies, subject to shareholder approval at the upcoming 29th AGM. Additionally, the Board noted the resignation of Mrs. Nikunj Aggarwal as Whole Time Director and approved the appointment of Mr. Sanskar Aggarwal as a new Whole Time Director (Additional) for five years. Mr. Atul Kumar was also appointed as Vice President-Sales (North), a Senior Management Personnel.